USA Opioid Induced Constipation Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Opioid Induced Constipation Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Opioid Induced Constipation Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Opioid Induced Constipation Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Nektar Therapeutics

    • AstraZeneca plc

    • Purdue Pharma

    • Pfizer

    • Shionogi & Co Ltd

    • Merck & Co Inc

    • Mallinckrodt Pharmaceuticals

    • Progenics Pharmaceuticals Inc

    • Salix Pharmaceuticals Inc

    • Ironwood Pharmaceutical Inc

    By Type:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Induced Constipation Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2016 to 2027

      • 1.3.2 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2016 to 2027

      • 1.3.3 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2016 to 2027

      • 1.3.4 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2016 to 2027

      • 1.3.5 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

      • 1.4.2 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

      • 1.4.3 USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Opioid Induced Constipation Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid Induced Constipation Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Lubiprostone

      • 3.4.2 Market Size and Growth Rate of Methyl Naltrexone Bromide

      • 3.4.3 Market Size and Growth Rate of Naldemedine

      • 3.4.4 Market Size and Growth Rate of Alvimopan

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Opioid Induced Constipation Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid Induced Constipation Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioid Induced Constipation Drugs in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Opioid Induced Constipation Drugs in Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of Opioid Induced Constipation Drugs in Online Pharmacies

    5 Market Analysis by Regions

    • 5.1 USA Opioid Induced Constipation Drugs Production Analysis by Regions

    • 5.2 USA Opioid Induced Constipation Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Opioid Induced Constipation Drugs Landscape Analysis

    • 6.1 West USA Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 6.2 West USA Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    7 South USA Opioid Induced Constipation Drugs Landscape Analysis

    • 7.1 South USA Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 7.2 South USA Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    8 Middle West USA Opioid Induced Constipation Drugs Landscape Analysis

    • 8.1 Middle West USA Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    9 Northeast USA Opioid Induced Constipation Drugs Landscape Analysis

    • 9.1 Northeast USA Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Nektar Therapeutics

        • 10.1.1 Nektar Therapeutics Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 AstraZeneca plc

        • 10.2.1 AstraZeneca plc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Purdue Pharma

        • 10.3.1 Purdue Pharma Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Pfizer

        • 10.4.1 Pfizer Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Shionogi & Co Ltd

        • 10.5.1 Shionogi & Co Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Merck & Co Inc

        • 10.6.1 Merck & Co Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Mallinckrodt Pharmaceuticals

        • 10.7.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Progenics Pharmaceuticals Inc

        • 10.8.1 Progenics Pharmaceuticals Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Salix Pharmaceuticals Inc

        • 10.9.1 Salix Pharmaceuticals Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Ironwood Pharmaceutical Inc

        • 10.10.1 Ironwood Pharmaceutical Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2016 to 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2016 to 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2016 to 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2016 to 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure USA Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Opioid Induced Constipation Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Opioid Induced Constipation Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid Induced Constipation Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Methyl Naltrexone Bromide

    • Figure Market Size and Growth Rate of Naldemedine

    • Figure Market Size and Growth Rate of Alvimopan

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Opioid Induced Constipation Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table USA Opioid Induced Constipation Drugs Production by Regions

    • Table USA Opioid Induced Constipation Drugs Production Share by Regions

    • Figure USA Opioid Induced Constipation Drugs Production Share by Regions in 2016

    • Figure USA Opioid Induced Constipation Drugs Production Share by Regions in 2021

    • Figure USA Opioid Induced Constipation Drugs Production Share by Regions in 2027

    • Table USA Opioid Induced Constipation Drugs Consumption by Regions

    • Table USA Opioid Induced Constipation Drugs Consumption Share by Regions

    • Figure USA Opioid Induced Constipation Drugs Consumption Share by Regions in 2016

    • Figure USA Opioid Induced Constipation Drugs Consumption Share by Regions in 2021

    • Figure USA Opioid Induced Constipation Drugs Consumption Share by Regions in 2027

    • Table West USA Opioid Induced Constipation Drugs Consumption by Types from 2016 to 2027

    • Table West USA Opioid Induced Constipation Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA Opioid Induced Constipation Drugs Consumption Share by Types in 2016

    • Figure West USA Opioid Induced Constipation Drugs Consumption Share by Types in 2021

    • Figure West USA Opioid Induced Constipation Drugs Consumption Share by Types in 2027

    • Table West USA Opioid Induced Constipation Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA Opioid Induced Constipation Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2016

    • Figure West USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2021

    • Figure West USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2027

    • Table South USA Opioid Induced Constipation Drugs Consumption by Types from 2016 to 2027

    • Table South USA Opioid Induced Constipation Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA Opioid Induced Constipation Drugs Consumption Share by Types in 2016

    • Figure South USA Opioid Induced Constipation Drugs Consumption Share by Types in 2021

    • Figure South USA Opioid Induced Constipation Drugs Consumption Share by Types in 2027

    • Table South USA Opioid Induced Constipation Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA Opioid Induced Constipation Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2016

    • Figure South USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2021

    • Figure South USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA Opioid Induced Constipation Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA Opioid Induced Constipation Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Share by Types in 2016

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Share by Types in 2021

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Share by Types in 2027

    • Table Middle West USA Opioid Induced Constipation Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Opioid Induced Constipation Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA Opioid Induced Constipation Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA Opioid Induced Constipation Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Share by Types in 2016

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Share by Types in 2021

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Share by Types in 2027

    • Table Northeast USA Opioid Induced Constipation Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Opioid Induced Constipation Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA Opioid Induced Constipation Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of AstraZeneca plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc

    • Figure Revenue and Market Share Analysis of AstraZeneca plc

    • Table Product and Service Introduction of AstraZeneca plc

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Shionogi & Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi & Co Ltd

    • Figure Sales and Growth Rate Analysis of Shionogi & Co Ltd

    • Figure Revenue and Market Share Analysis of Shionogi & Co Ltd

    • Table Product and Service Introduction of Shionogi & Co Ltd

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

    • Table Company Profile and Development Status of Progenics Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals Inc

    • Table Product and Service Introduction of Progenics Pharmaceuticals Inc

    • Table Company Profile and Development Status of Salix Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals Inc

    • Table Product and Service Introduction of Salix Pharmaceuticals Inc

    • Table Company Profile and Development Status of Ironwood Pharmaceutical Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceutical Inc

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceutical Inc

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceutical Inc

    • Table Product and Service Introduction of Ironwood Pharmaceutical Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.